HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diverse antibody responses to SARS-CoV-2 infection in patients with end-stage kidney disease undergoing hemodialysis.

AuthorsHong Yu, Pei Wang
JournalTherapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (Ther Apher Dial) Vol. 26 Issue 2 Pg. 473-474 (04 2022) ISSN: 1744-9987 [Electronic] Australia
PMID34655276 (Publication Type: Letter)
Topics
  • Antibody Formation
  • COVID-19 (therapy)
  • Humans
  • Kidney Failure, Chronic (therapy)
  • Renal Dialysis
  • SARS-CoV-2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: